Compensated Awareness Post View
Disclaimer
$EAPH Headline News:
Monday, September 26, 2011
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Marketwire (Mon, Sep 26)
Thursday, September 22, 2011
Easton Pharmaceuticals Announces Retaining Winston & Strawn For Patent Application Submission
Marketwire (Thu, Sep 22)
Wednesday, September 21, 2011
Easton Pharmaceuticals Announces Receiving Two Financing Proposals
Marketwire (Wed, Sep 21)
Thursday, September 15, 2011
Easton Pharmaceuticals Announces It has Entered into Discussions For Distribution Agreement In East Asia
Marketwire (Thu, Sep 15)
Tuesday, September 13, 2011
Easton Pharmaceuticals to Enter Into Clinical Safety Trials of VIORRA for North American Marke
tMarketwire (Tue, Sep 13)
Tuesday, August 2, 2011
Easton Pharmaceuticals Announces Update On Patents
Marketwire (Tue, Aug 2)
Friday, July 22, 2011
Easton Pharmaceuticals Announces Projections of $15 Million in Revenue For 2012 From The Company's First Territory Launch of VIORRA in Mexico
Marketwire (Fri, Jul 22)
Tuesday, July 19, 2011
Easton Pharmaceuticals Announces Dr. Asa Hershoff, Prominent Herbal and Homeopathic Medicine Expert and Author, as a Senior Consultant to Research and DevelopmentMarketwire (Tue, Jul 19)
Tuesday, July 12, 2011
Easton Pharmaceuticals Announces VIORRA Regulatory Filing in Mexico: Expected to be First Territory LaunchMarketwire (Tue, Jul 12)
Wednesday, June 22, 2011
CORRECTION: Easton Pharmaceuticals Announces Dr. Jack Barkin MD, FICS, FACS, DABU, MHM, CCPE, FRCS (c) Has Accepted The Position of Senior Vice-President and Chief Medical OfficerMarketwire (Wed, Jun 22)
Tuesday, June 21, 2011
Easton Pharmaceuticals Announces Dr. Jack Barkin MD, World-Renowned Expert on Disorders of Sexual Dysfunction, Has Accepted The Position as Senior Vice-President, Chief Medical OfficerMarketwire (Tue, Jun 21)
Tuesday, June 14, 2011
Easton Pharmaceuticals Announces The Appointment of John Easton as Interim Chief Executive OfficerMarketwire (Tue, Jun 14)
Friday, June 3, 2011
Easton Pharmaceuticals Announces Plan to Introduce Products for Treating Female Sexual Arousal Disorders Providing Alternatives to Ineffective Hormonal TherapiesMarketwire (Fri, Jun 3)
Monday, December 20, 2010
Easton Pharmaceuticals Announces 2011 "Fast-to-Market" Plan To Introduce Products For Treating Female Sexual Arousal Disorders and Provide Alternative To Ineffective Hormonal TherapiesMarketwire (Mon, Dec 20)
